PETS
PETMED EXPRESS, INC.Marquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $3.09 | $2.25 | -27% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $3.13 | $2.25 | -28% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| D.E. Shaw | Q3 2024 | Q4 2025 | → $2.00 | -36% |
| AQR Capital Management | Q3 2024 | Q3 2025 | → $3.10 | -1% |
| Millennium Management | Q3 2024 | Q3 2025 | → $3.10 | -1% |
| Two Sigma Investments | Q3 2024 | Q1 2025 | → $4.25 | +36% |
| Maverick Capital 7× in & out | Q4 2023 | Q1 2024 | → $5.28 | -33% |
| Coatue Management 2× in & out | Q1 2020 | Q2 2020 | → $28 | +22% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at PETMED EXPRESS INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 9, 2026 — the most recent Form 4 on file — not from today.
- Form 40001213900-26-066871Jun 9, 2026
- Form 40001040130-26-000004Jan 23, 2026
- Form 40001040130-25-000088Nov 14, 2025
- Form 40002035815-25-000011Nov 3, 2025
- Form 40001040130-25-000081Nov 3, 2025
- Form 40001789515-25-000003Nov 3, 2025
- Form 40002028705-25-000004Nov 3, 2025
- Form 40002064538-25-000002Nov 3, 2025
- Form 40002035815-25-000009Sep 11, 2025
- Form 40002035815-25-000007Sep 11, 2025
- Form 40001903596-25-000404Aug 14, 2025
- Form 40001903596-25-000383Aug 4, 2025
- Form 40001213900-25-066628Jul 22, 2025
- Form 40001903596-25-000348Jul 21, 2025
- Form 40001903596-25-000346Jul 18, 2025
Fundamentals
XBRL · PETMED EXPRESS, INC.Annual figures sourced directly from PETMED EXPRESS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for PETMED EXPRESS INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-KAnnual reportJun 2, 2026
- 8-KMaterial eventJun 2, 2026
- 8-KMaterial eventMay 21, 2026
- 10-QQuarterly reportFeb 5, 2026
- 8-KMaterial eventJan 23, 2026
- 8-K/AMaterial event (amended)Dec 29, 2025
- 10-QQuarterly reportDec 19, 2025
- 10-QQuarterly reportDec 19, 2025
- DEF 14AProxy statementDec 10, 2025
- 8-KMaterial eventDec 9, 2025
- 8-KMaterial eventNov 26, 2025
- 8-KMaterial eventNov 13, 2025
- 8-KMaterial eventOct 21, 2025
- 8-KMaterial eventOct 14, 2025
- 10-KAnnual reportOct 14, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | open | $3.13 | $2.25 | -28% |
| Two Sigma Investments | Q3 2024 | Q1 2025 | $3.13 | $4.25 | +36% |
| D.E. Shaw | Q3 2024 | Q4 2025 | $3.13 | $2.00 | -36% |
| AQR Capital Management | Q3 2024 | Q3 2025 | $3.13 | $3.10 | -1% |
| Millennium Management | Q3 2024 | Q3 2025 | $3.13 | $3.10 | -1% |
| Renaissance Technologies | Q3 2024 | open | $3.09 | $2.25 | -27% |
| Maverick Capital | Q4 2023 | Q1 2024 | $7.90 | $5.28 | -33% |
| Maverick Capital | Q4 2022 | Q2 2023 | $19 | $15 | -24% |
| Maverick Capital | Q1 2021 | Q2 2021 | $33 | $26 | -21% |
| Maverick Capital | Q2 2020 | Q3 2020 | $28 | $28 | -2% |
| Coatue Management | Q1 2020 | Q2 2020 | $23 | $28 | +22% |
| Coatue Management | Q3 2018 | Q4 2018 | $29 | $21 | -29% |
| Maverick Capital | Q3 2018 | Q4 2018 | $29 | $21 | -29% |
| Maverick Capital | Q1 2018 | Q2 2018 | $34 | $27 | -21% |
| Maverick Capital | Q3 2017 | Q4 2017 | $36 | $29 | -21% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.